Skip to content
Use caution Drug recall · FDA · Published July 28, 2015

Fresenius Kabi Recalls Hydralazine Due to Incorrect Expiration Date

Fresenius Kabi USA recalls 93,000 vials of Hydralazine Hydrochloride Injection due to an incorrect expiration date printed on the secondary packaging.

🇺🇸 FDA recall #D-1327-2015DrugFresenius Kabi ›
Take action

Contact the company

Recalling firmFresenius Kabi USA, LLC3 Corporate Dr · Lake Zurich, IL 60047-8930
✎ GovInfoNow plain-language explainer

What happened, in plain English

Fresenius Kabi USA, LLC is recalling a specific lot of Hydralazine Hydrochloride Injection because the expiration date printed on the tray does not match the actual expiration. The product in question contains 20 mg/mL of the drug in a 1 mL fill within a 2 mL single-dose vial. This discrepancy affects the ability to verify how long the medication remains effective and safe for use. Read more at govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20.

Source Summary by GovInfoNow · govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1327-2015

Cite this page

“Fresenius Kabi Recalls Hydralazine Due to Incorrect Expiration Date.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43881-fresenius-kabi-usa-llc-recalls-hydralazine-hydrochloride-injection-usp-20. Based on FDA recall #D-1327-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1327-2015%22&limit=1).

Why it’s dangerous

The hazard stems from a labeling error where the secondary packaging displays an incorrect expiration date ('11/06' instead of '11/2016'). This creates confusion regarding the product's shelf life, potentially leading to the use of medication that may have degraded or lost potency.

Who’s affected

Healthcare providers, pharmacies, and patients who have received or possess Hydralazine Hydrochloride Injection with NDC 63323-614-01 and Lot #6110593. These individuals are at risk of using medication past its verified expiration date if the error is not identified.

How to tell if you have this one

Check for Hydralazine Hydrochloride Injection, USP, 20 mg/mL, in a 2 mL single-dose vial. Look specifically for NDC 63323-614-01 and Lot #6110593. Verify if the expiration date printed on the tray is '11/06', which is the incorrect date associated with this recall.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify Affected Product

    Check your inventory for Hydralazine Hydrochloride Injection, USP, 20 mg/mL, NDC 63323-614-01, Lot #6110593.

  2. Verify Expiration Date

    Confirm if the expiration date printed on the tray is '11/06', which indicates the product is part of this recall.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 7 months after the firm started it.

1. Firm started the recall: Jul 28, 201512. FDA classified it Class III: Aug 12, 201523. Published in FDA’s Enforcement Report: Aug 19, 201534. FDA terminated the recall: Mar 8, 2016420152016
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Fresenius Kabi recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1327-2015 (July 28, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1327-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA